Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Microbot Medical Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +5 vs. Q4 2022
- Shares held
- 1.42M
- −72.8K (−4.9%) vs. Q4 2022
- Total value
- $2.94M
- −$1.54M (−34.3%) vs. Q4 2022
- New holders
- 6
- 7 more added
- Sold out
- 1
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $22.1M |
| Q1 2026 | 79 | $34.3M |
| Q4 2025 | 71 | $22.8M |
| Q3 2025 | 68 | $27.4M |
| Q2 2025 | 50 | $11.1M |
| Q1 2025 | 44 | $3.26M |
| Q4 2024 | 39 | $1.24M |
| Q3 2024 | 26 | $933.4K |
| Q2 2024 | 36 | $1.11M |
| Q1 2024 | 33 | $1.77M |
| Q4 2023 | 36 | $2.49M |
| Q3 2023 | 31 | $1.40M |
| Q2 2023 | 28 | $3.36M |
| Q1 2023 | 29 | $2.94M |
| Q4 2022 | 24 | $4.48M |
| Q3 2022 | 23 | $3.84M |
| Q2 2022 | 25 | $3.60M |
| Q1 2022 | 27 | $4.65M |
| Q4 2021 | 27 | $6.10M |
| Q3 2021 | 25 | $5.47M |
| Q2 2021 | 29 | $6.00M |
| Q1 2021 | 25 | $6.77M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Microbot Medical Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 600,000 | $1.25M | 0.03% | −90,000−13.0% | Reduced |
| Vanguard Group Inc | 260,823 | $542.5K | 0.00% | −9,096−3.4% | Reduced |
| BlackRock Inc. | 152,554 | $317.3K | 0.00% | +474+0.3% | Added |
| AlphaCentric Advisors LLC | 100,000 | $208.0K | 0.14% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 66,207 | $137.7K | 0.00% | −26,248−28.4% | Reduced |
| Geode Capital Management, LLC | 52,922 | $110.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 39,089 | $81.3K | 0.00% | +2,751+7.6% | Added |
| State Street Corp | 26,070 | $54.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,243 | $48.3K | 0.00% | +23,243 | New |
| Renaissance Technologies LLC | 20,395 | $42.0K | 0.00% | +2,400+13.3% | Added |
| Bank of New York Mellon Corp | 15,392 | $32.0K | 0.00% | −150−1.0% | Reduced |
| Millennium Management LLC | 14,862 | $31.0K | 0.00% | +14,862 | New |
| Northern Trust Corp | 13,446 | $28.0K | 0.00% | +3,017+28.9% | Added |
| Cetera Advisor Networks LLC | 10,101 | $21.0K | 0.00% | −900−8.2% | Reduced |
| Steward Partners Investment Advisory, LLC | 5,800 | $12.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,289 | $11.0K | 0.00% | +1,567+42.1% | Added |
| UBS Group AG | 4,547 | $9.46K | 0.00% | +2,980+190.2% | Added |
| Advisor Group Holdings, Inc. | 2,917 | $6.07K | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 1,473 | $3.06K | 0.00% | +1,473 | New |
| Royal Bank of Canada | 571 | $1.00K | 0.00% | +570+57,000.0% | Added |
| Wells Fargo & Company | 187 | $390 | 0.00% | 00.0% | Unchanged |
| Bourgeon Capital Management LLC | 11 | $23 | 0.00% | −2−15.4% | Reduced |
| Bank of America Corp | 2 | $4 | 0.00% | −8−80.0% | Reduced |
| Pacific Center for Financial Services | 1 | $3 | 0.00% | +1 | New |
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 300 | $0 | 0.00% | +300 | New |
| Front Row Advisors LLC | 1 | $0 | 0.00% | +1 | New |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |